These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. FimH antagonists: bioisosteres to improve the in vitro and in vivo PK/PD profile. Kleeb S; Pang L; Mayer K; Eris D; Sigl A; Preston RC; Zihlmann P; Sharpe T; Jakob RP; Abgottspon D; Hutter AS; Scharenberg M; Jiang X; Navarra G; Rabbani S; Smiesko M; Lüdin N; Bezençon J; Schwardt O; Maier T; Ernst B J Med Chem; 2015 Mar; 58(5):2221-39. PubMed ID: 25666045 [TBL] [Abstract][Full Text] [Related]
26. "Nanoantibiotics": a new paradigm for treating infectious diseases using nanomaterials in the antibiotics resistant era. Huh AJ; Kwon YJ J Control Release; 2011 Dec; 156(2):128-45. PubMed ID: 21763369 [TBL] [Abstract][Full Text] [Related]
27. Sexually transmitted Escherichia coli urethritis and orchiepididymitis. Dan M; Gottesman T; Schwartz O; Tsivian A; Gophna U; Rokney A Sex Transm Dis; 2012 Jan; 39(1):16-7. PubMed ID: 22183838 [TBL] [Abstract][Full Text] [Related]
28. Payload hardware and experimental protocol development to enable future testing of the effect of space microgravity on the resistance to gentamicin of uropathogenic Escherichia coli and its σ Matin AC; Wang JH; Keyhan M; Singh R; Benoit M; Parra MP; Padgen MR; Ricco AJ; Chin M; Friedericks CR; Chinn TN; Cohen A; Henschke MB; Snyder TV; Lera MP; Ross SS; Mayberry CM; Choi S; Wu DT; Tan MX; Boone TD; Beasley CC; Piccini ME; Spremo SM Life Sci Space Res (Amst); 2017 Nov; 15():1-10. PubMed ID: 29198308 [TBL] [Abstract][Full Text] [Related]
29. Nanotechnology-based drug delivery systems for control of microbial biofilms: a review. Dos Santos Ramos MA; Da Silva PB; Spósito L; De Toledo LG; Bonifácio BV; Rodero CF; Dos Santos KC; Chorilli M; Bauab TM Int J Nanomedicine; 2018; 13():1179-1213. PubMed ID: 29520143 [TBL] [Abstract][Full Text] [Related]
30. Gold nanoparticles: A plausible tool to combat neurological bacterial infections in humans. Rizvi SMD; Hussain T; Ahmed ABF; Alshammari TM; Moin A; Ahmed MQ; Barreto GE; Kamal MA; Ashraf GM Biomed Pharmacother; 2018 Nov; 107():7-18. PubMed ID: 30075371 [TBL] [Abstract][Full Text] [Related]
31. Multiple strategies to activate gold nanoparticles as antibiotics. Zhao Y; Jiang X Nanoscale; 2013 Sep; 5(18):8340-50. PubMed ID: 23893008 [TBL] [Abstract][Full Text] [Related]
32. Nanomaterials for alternative antibacterial therapy. Hemeg HA Int J Nanomedicine; 2017; 12():8211-8225. PubMed ID: 29184409 [TBL] [Abstract][Full Text] [Related]
33. An exploratory study of dog park visits as a risk factor for exposure to drug-resistant extra-intestinal pathogenic E. coli (ExPEC). Ahmed LN; Price LB; Graham JP BMC Res Notes; 2015 Apr; 8():137. PubMed ID: 25886556 [TBL] [Abstract][Full Text] [Related]
34. Luteolin decreases the attachment, invasion and cytotoxicity of UPEC in bladder epithelial cells and inhibits UPEC biofilm formation. Shen XF; Ren LB; Teng Y; Zheng S; Yang XL; Guo XJ; Wang XY; Sha KH; Li N; Xu GY; Tian HW; Wang XY; Liu XK; Li J; Huang N Food Chem Toxicol; 2014 Oct; 72():204-11. PubMed ID: 25051393 [TBL] [Abstract][Full Text] [Related]
35. Use of nanoparticles with Escherichia coli receptors for prophylaxis of recurrent urinary tract infections in children. Beyitler I; Kavukcu S Med Hypotheses; 2017 Feb; 99():67. PubMed ID: 28110702 [No Abstract] [Full Text] [Related]
36. Risk factors for extended-spectrum beta-lactamase positivity in uropathogenic Escherichia coli isolated from community-acquired urinary tract infections. Azap OK; Arslan H; Serefhanoğlu K; Colakoğlu S; Erdoğan H; Timurkaynak F; Senger SS Clin Microbiol Infect; 2010 Feb; 16(2):147-51. PubMed ID: 19689464 [TBL] [Abstract][Full Text] [Related]
37. Silver nanoparticles as potential antibacterial agents. Franci G; Falanga A; Galdiero S; Palomba L; Rai M; Morelli G; Galdiero M Molecules; 2015 May; 20(5):8856-74. PubMed ID: 25993417 [TBL] [Abstract][Full Text] [Related]
39. Virulence factors of uropathogenic E. coli and their interaction with the host. Lüthje P; Brauner A Adv Microb Physiol; 2014; 65():337-72. PubMed ID: 25476769 [TBL] [Abstract][Full Text] [Related]